中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

树突状细胞与丙型病毒性肝炎

魏峰 李俊卿 周俊英

引用本文:
Citation:

树突状细胞与丙型病毒性肝炎

详细信息
  • 中图分类号: R392

Dendritic cells and hepatitis C

  • 摘要: 树突状细胞(DC)是目前已知体内功能最强的抗原递呈细胞,在丙型肝炎病毒(HCV)感染的患者,DC功能减弱可促进病毒的持续感染,造成疾病的慢性化。目前DC成为HCV疫苗的研究重点,可能成为治疗慢性丙型肝炎(CHC)的有效免疫学方法,本文就DC与丙型肝炎的关系及其在治疗中的应用前景作一综述。

     

  • [1]Pachiadakis I, Pollara G, Chain BM, et al.Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence[J].Lancet Infect Dis, 2005, 5 (5) :296-304.
    [2]Groux H, Foumier N, Cottrez F.Role of dendritic cells in the generation of regulatory T cells[J].Semin Immunol, 2004, 6 (2) :99-106.
    [3]Onishi Y, Fehervari Z, Yamaguchi T, et al.Foxp3+natural resulatery T cells pmferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation[J].Proc Natl Acad Sci, 2008, 105 (29) :10113-10118.
    [4]Kanto T, Hayashi N, Takehara T, et al.Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals[J].J Immunol, 1999, 162 (9) :5584-5591.
    [5]Li W, Krishnadas DK, Kumar R, et al.Priming and stimulation of hepatitis C virus-specific CD4+and CD8+T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals:implications for prophylactic vaccine[J].Int Immunol, 2008, 20 (1) :89-104.
    [6]Amjad M, Abdel-Haq N, Faisal M, et al.Decreased interferon-alpha production and impaired regulatory function of plasmacytoid dendritic cells induced by the hepatitis C virus NS 5 protein[J].Microbiol Immunol, 2008, 52 (10) :499-507.
    [7]Bain C, Fatmi A, Zoulim F, et al.Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection[J].Gastroenterology, 2001, 120 (33) :512-524.
    [8]李军, 冯志华, 聂青和, 等.人DC-SIGN真核表达载体的构建及在K-562细胞中的表达[J].肝脏, 2006, 11 (1) :24-27.
    [9]王敏, 王辉, 蒋小玲, 等.DC-SIGNR基因多态性与肝功能和HCV病毒载量的相关性[J].中国医师进修杂志, 2007, 30 (30) :3-5.
    [10]Auffermann-Gretzinger S, Keeffe EB, Levy S.Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection[J].Blood, 2001, 97 (18) :3171-3176.
    [11]Dolganiuc A, Kodys K, Kopasz A, et al.Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and anti-inflammatory cytokines and inhibit tendritic cell differentiation[J].J Immunol, 2003, 170 (11) :5615-5624.
    [12]Zimmermann M, Flechsig C, La Monica N, et al.Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes[J].J Hepatol, 2008, 48 (1) :51-60.
    [13]Dolganiuc A, Paek E, Kodys K, et al.Myeloid den-dritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes[J].Gastroenterology.2008, 135 (6) :2119-2127.
    [14]Lai WK, Curbishley SM, Goddard S, et al.Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function[J].J Hepatol, 2007, 47 (3) :338-347.
    [15]Klade CS, Wedemeyer H, Berg T, et al.Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41[J].Gastroenterology, 2008, 134 (5) :1385-1395.
    [16]Firbas C, Boehm T, Buerger V, et al.Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine[J].Vaccine, 2010, 28 (12) :2397-2407.
    [17]Chua BY, Eriksson EM, Brown LE, et al.A self-adj-uvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection[J].Vaccine, 2008, 26 (37) :4866-4875.
    [18]Gowans EJ, Roberts S, Jones K, et al.A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals[J].J Hepatol, 2010, 53 (4) :599-607.
    [19]Zabaleta A, Llopiz D, Arribillaga L, et al.Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein[J].Mol Ther, 2008, 16 (1) :210-217.
    [20]Yu H, Babiuk LA, van Drunen Littel-van den Hurk S.Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity[J].J Viral Hepat, 2008, 15 (6) :459-470.
    [21]Forde KA, Reddy KR.Hepatitis C virus infection and immunomodulatory therapies[J].Clin Liver Dis, 2009, 13 (3) :391-401.
  • 加载中
计量
  • 文章访问数:  3288
  • HTML全文浏览量:  17
  • PDF下载量:  807
  • 被引次数: 0
出版历程
  • 出版日期:  2011-05-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回